Ti Jun Yu
Directeur/Membre du Conseil chez Shanghai Mingyuan Enterprise Group Co. Ltd.
Profil
Ti Jun Yu is currently serving as the Vice Chairman at Eastern China Health Education Research Society.
Additionally, he holds the position of Director & Vice President at Shanghai Mingyuan Enterprise Group Co. Ltd.
since 2010.
He is also the Executive Director & Vice President-Corporate at China Association of Health Education since 2011 and the Vice President at Shanghai Corporate Health Management Promotion Committee.
Previously, Mr. Yu worked as a Non-Executive Director at Mingyuan Medicare Development Co. Ltd.
from 2004 to 2016.
Postes actifs de Ti Jun Yu
| Sociétés | Poste | Début |
|---|---|---|
| Shanghai Mingyuan Enterprise Group Co. Ltd. | Directeur/Membre du Conseil | 19/03/2010 |
| China Association of Health Education | Directeur/Membre du Conseil | 19/03/2010 |
| Eastern China Health Education Research Society | Directeur/Membre du Conseil | 19/03/2010 |
| Shanghai Corporate Health Management Promotion Committee | Corporate Officer/Principal | - |
Anciens postes connus de Ti Jun Yu
| Sociétés | Poste | Fin |
|---|---|---|
| MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Directeur/Membre du Conseil | 20/05/2016 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Mingyuan Medicare Development Co. Ltd.
 Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
| Shanghai Mingyuan Enterprise Group Co. Ltd. | |
| China Association of Health Education | |
| Eastern China Health Education Research Society | |
| Shanghai Corporate Health Management Promotion Committee |
